The Public Hospital "Carlos III" offers genetic tests for HIV+ Patients

[blondbeauty]

http://www.vihpositivo.com/testgenetico230507.htm
MADRID, 22 May. (EUROPE PRESS) the Hospital Carlos III of the Community of Madrid, through its Service of Infectious Diseases, makes of voluntary form genetic test drug to patients with VIH to determine if a antirretroviral drug can cause adverse answers to them. These tests, that they are always made after an informed consent, help to reduce the toxicity problems that can cause the antirretroviral medication and that affects to between a 20% and to 30% of the VIH patients. With all these tests the treatment to the genetic profile of each patient can be adapted, reducing the adverse effects and fitting the doses of medicines with the objective to optimize the treatment. The Hospital Carlos III is pioneering in the accomplishment of a genetic test that determines if a antirretroviral, concretely abacavir, causes hypersensitivity or allergy in the patients. It is very important to detect this data, since it is had to retire immediately the medication to the patient and to indicate it in his clinical history, since a second treatment with this drug can cause very serious consequences for the patient. The activity of the Hospital Carlos III in this matter has taken to the Foundation Ramon Areces to grant a scholarship from investigation to the hospital to identify those genetic markers associate to the appearance of adverse reactions in the patients. The objective to classify this sub-group of patients is to adapt the therapy to its physiological characteristics or their farmacogenético profile. In this work some of the more important adverse effects of the drugs that are used very frequently in the antirretroviral therapy, with the purpose of predicting the risk of development of toxicity study to individualize the therapy. With it the quality of life of the patient would improve and sanitary costs derived from the treatment of the adverse effects would be reduced. The Service of Infectious Diseases of the Hospital Carlos III is specialized in the treatment and the investigation of the VIH. The center gives attendance more than 2,000 patients every year and, at the moment, it makes the test of five new antirretrovirales drugs. This service annually publishes half hundred of scientific articles on the VIH in national and international magazines of forward edge. The equipment directed by doctor Juan González-Lahoz is integrated by doctors, chemistries, phamacists and biologists, who dedicate their work to look for new advances in the fight against AIDS. Tests, volunteers, look for to reduce the toxicity to the antirretrovirales, that affects to between 20% and 30% of the patients.